|
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer
and
to the FCA in Microsoft Word format
if possible)i
|
||||||
|
|
||||||
|
1a. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attachedii:
|
AstraZeneca
PLC
|
|||||
|
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if
appropriate)
|
||||||
|
Non-UK Issuer
|
|
|||||
|
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
|
||||||
|
An
acquisition or disposal of voting rights
|
X
|
|||||
|
An
acquisition or disposal of financial instruments
|
|
|||||
|
An
event changing the breakdown of voting rights
|
|
|||||
|
Other
(please specify)iii:
|
|
|||||
|
3. Details of person subject to the notification
obligationiv
|
||||||
|
Name
|
The Capital Group Companies, Inc. ("CGC")
|
|||||
|
City
and country of registered office (if applicable)
|
Los
Angeles, CA 90071, USA
|
|||||
|
4. Full name of shareholder(s) (if different from 3.)v
|
||||||
|
Name
|
|
|||||
|
City
and country of registered office (if applicable)
|
|
|||||
|
5. Date on which the threshold was crossed or
reachedvi:
|
10
August 2017
|
|||||
|
6. Date on which issuer notified
(DD/MM/YYYY):
|
14
August 2017
|
|||||
|
7. Total positions of person(s) subject to the notification
obligation
|
||||||
|
|
% of
voting rights attached to shares (total of 8. A)
|
% of
voting rights through financial instruments(total of 8.B 1 + 8.B
2)
|
Total
of both in % (8.A + 8.B)
|
Total
number of voting rights of issuervii
|
||
|
Resulting
situation on the date on which threshold was crossed or
reached
|
4.979%
|
0.000%
|
4.979%
|
1,265,794,991
|
||
|
Position
of previous notification (if
applicable)
|
5.001%
|
0.000%
|
5.001%
|
|
||
|
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reachedviii
|
|||||||||
|
A: Voting rights attached to shares
|
|||||||||
|
Class/type ofshares
ISIN
code (if possible)
|
Number of voting rightsix
|
% of voting rights
|
|||||||
|
Direct
(Art 9
of Directive 2004/109/EC) (DTR5.1)
|
Indirect
(Art 10
of Directive 2004/109/EC) (DTR5.2.1)
|
Direct
(Art 9
of Directive 2004/109/EC) (DTR5.1)
|
Indirect
(Art 10
of Directive 2004/109/EC) (DTR5.2.1)
|
||||||
|
Ordinary
(GB0009895292)
|
|
51,247,123
|
|
4.049%
|
|||||
|
ADRs
(US0463531089)
|
|
11,782,188
|
|
0.931%
|
|||||
|
|
|
|
|
|
|||||
|
SUBTOTAL 8. A
|
63,029,311
|
4.979%
|
|||||||
|
|
|||||||||
|
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
|
|||||||||
|
Type of financial instrument
|
Expirationdatex
|
Exercise/Conversion Periodxi
|
Number of voting rights that may be acquired if the instrument
is
exercised/converted.
|
% of voting rights
|
|||||
|
N/A
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
SUBTOTAL 8. B 1
|
|
|
|||||
|
|
|||||||||
|
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1
(b))
|
|||||||||
|
Type of financial instrument
|
Expirationdatex
|
Exercise/Conversion Period xi
|
Physical or cash
settlementxii
|
Number of voting rights
|
% of voting rights
|
||||
|
N/A
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
|
|
SUBTOTAL 8.B.2
|
|
|
||||
|
9. Information in relation to the person subject to the
notification obligation (please mark the
applicable
box with an "X")
|
||||
|
Person
subject to the notification obligation is not controlled by any
natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuerxiii
|
|
|||
|
Full
chain of controlled undertakings through which the voting rights
and/or thefinancial instruments are effectively held starting with
the ultimate controlling natural person or legal entityxiv (please add additional rows as
necessary)
|
X
|
|||
|
Namexv
|
% of voting rights if it equals or is higher than the notifiable
threshold
|
% of voting rights through financial instruments if it equals or is
higher than the notifiable threshold
|
Total of both if it equals or is higher than the notifiable
threshold
|
|
|
The Capital Group Companies, Inc.
Holdings by CG Management companies are set out
below:
|
|
|
|
|
|
● Capital Guardian Trust Company1
|
|
|
|
|
|
● Capital International, Inc.1
|
|
|
|
|
|
● Capital International Limited1
|
|
|
|
|
|
● Capital International Sàrl1
|
|
|
|
|
|
● Capital Research and Management Company2
|
|
|
|
|
|
|
|
|
|
|
|
1Indirect subsidiaries of
Capital Research and Management Company.
2Subsidiary of The Capital
Group Companies, Inc.
|
||||
|
10. In case of proxy voting, please identify:
|
||||
|
Name of
the proxy holder
|
|
|||
|
The
number and % of voting rights held
|
|
|||
|
The
date until which the voting rights will be held
|
|
|||
|
|
||||
|
11. Additional informationxvi
|
||||
|
CGC is
the parent company of Capital Research and Management Company
("CRMC"). CRMC is a U.S.-based investment management company
that manages the American Funds family of mutual funds. CRMC
manages equity assets for various investment companies through
three divisions, Capital Research Global Investors, Capital
International Investors and Capital World Investors. CRMC in
turn is the parent company of Capital Group International, Inc.
("CGII"), which in turn is the parent company of five investment
management companies ("CGII management companies"): Capital
Guardian Trust Company, Capital International, Inc., Capital
International Limited, Capital International Sàrl and Capital
International K.K. The CGII management companies primarily
serve as investment managers to institutional clients.
Neither
CGC nor any of its affiliates own shares of AstraZeneca PLC for its
own account. Rather, the shares reported on this Notification
are owned by accounts under the discretionary investment management
of one or more of the investment management companies described
above.
|
||||
|
Place of completion
|
Los
Angeles, CA, USA
|
|
Date of completion
|
11
August 2017
|
|
Date:
14 August 2017
|
By: /s/
Adrian Kemp
|
|
|
Name:
Adrian Kemp
|
|
|
Title:
Company Secretary
|